By binding to CMV through sialic acids expressed on its glyosidic moiety, PTX3 was demonstrated to be effective in averting CMV infection and reactivation in selected in vivo and in vitro models of infection (30). The gene discussed is PTX3; the disease is cytomegalovirus infection.